Literature DB >> 9343271

Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment.

C Rongen-Westerlaken1, L Corel, J van den Broeck, G Massa, J Karlberg, K Albertsson-Wikland, R W Naeraa, J M Wit.   

Abstract

As Northern Europeans are currently the tallest people in the world, specific growth charts for girls with Turner's Syndrome from this area are needed. Based on height and weight measurements from 598 girls with Turner's Syndrome (372 from the Netherlands, 108 from Denmark, 118 from Sweden) not treated with growth-promoting substances and without signs of spontaneous puberty, we constructed growth charts for height-for-age, height-velocity-for-age, weight-for-age, weight-for-height and Body Mass Index for age. Reference tables and regression equations for mean and standard deviation are provided allowing calculation of Standard Deviation Scores. The height and height velocity curves show a low birth length, gradual deviation from the normal percentile curves without pubertal growth spurt, and a prolonged growth until the early 20s. Mean adult height was 146.9 +/- 7.8 cm. Mean weight-for-age was lower than in normal reference children but height-adjusted weight was higher, except in infancy and early childhood. Further studies are required on the factors influencing the weight-height relationship in Turner's Syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343271     DOI: 10.1111/j.1651-2227.1997.tb15174.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  24 in total

Review 1.  Long-term results of growth hormone therapy in Turner syndrome.

Authors:  J H Bramswig
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

2.  Towards evidence based referral criteria for growth monitoring.

Authors:  S van Buuren; P van Dommelen; G R J Zandwijken; F K Grote; J M Wit; P H Verkerk
Journal:  Arch Dis Child       Date:  2004-04       Impact factor: 3.791

Review 3.  Sex hormone replacement in Turner syndrome.

Authors:  Christian Trolle; Britta Hjerrild; Line Cleemann; Kristian H Mortensen; Claus H Gravholt
Journal:  Endocrine       Date:  2011-12-07       Impact factor: 3.633

Review 4.  Turner syndrome and GH treatment: the state of the art.

Authors:  A M Pasquino
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

5.  Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group.

Authors:  A M Pasquino; I Pucarelli; M Segni; L Tarani; V Calcaterra; D Larizza
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

Review 6.  Growth and nutrition disorders in children with cerebral palsy.

Authors:  Michelle N Kuperminc; Richard D Stevenson
Journal:  Dev Disabil Res Rev       Date:  2008

7.  Nutritional differences in neurologically impaired children.

Authors:  Alura Riley; Christina Vadeboncoeur
Journal:  Paediatr Child Health       Date:  2012-11       Impact factor: 2.253

8.  Response to three years of growth hormone therapy in girls with Turner syndrome.

Authors:  Hong Kyu Park; Hae Sang Lee; Jung Hee Ko; Il Tae Hwang; Jin Soon Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-03-31

9.  Growth failure and outcome in Rett syndrome: specific growth references.

Authors:  Daniel Charles Tarquinio; Kathleen J Motil; Wei Hou; Hye-Seung Lee; Daniel G Glaze; Steven A Skinner; Jeff L Neul; Fran Annese; Lauren McNair; Judy O Barrish; Suzanne P Geerts; Jane B Lane; Alan K Percy
Journal:  Neurology       Date:  2012-10-03       Impact factor: 9.910

10.  Recombinant human growth hormone in the treatment of Turner syndrome.

Authors:  Bessie E Spiliotis
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.